Schmidt, Jürgen

Link to this page

Authority KeyName Variants
a6853411-93b0-41bb-a8c4-92a5f32d42c6
  • Schmidt, Jürgen (1)
Projects
No records found.

Author's Bibliography

Synthesis, characterization and in vitro cytotoxicity studies of platinum(IV) complexes with thiouracil ligands

Vetter, Cornelia; Kaluđerović, Goran N.; Paschke, Reinhard; Kluge, Ralph; Schmidt, Jürgen; Steinborn, Dirk

(Elsevier, 2010)

TY  - JOUR
AU  - Vetter, Cornelia
AU  - Kaluđerović, Goran N.
AU  - Paschke, Reinhard
AU  - Kluge, Ralph
AU  - Schmidt, Jürgen
AU  - Steinborn, Dirk
PY  - 2010
UR  - https://cer.ihtm.bg.ac.rs/handle/123456789/3175
AB  - Reactions of [PtMe3(bpy)(Me2CO)][BF4] (2) with the thionucleobases 2-thiouracil (s2Ura), 4-thiouracil (s 4Ura) and 2,4-dithiouracil (s2s4Ura) resulted in the formation of complexes of the type [PtMe3 (bPy)(L-κS)] [BF4] (L= s2Ura, 3; s4Ura, 4; s 2s4Ura, 5). The complexes were characterized by NMR spectroscopy (1H, 13C, 195Pt), IR spectroscopy as well as microanalyses. The coordination through the C4=S groups (4, 5) was additionally confirmed by DFT calculations, where it was shown that these complexes [PtMe3(bpy)(L-κS4)]+ (L=s 4Ura, s2s4Ura) are about 5.8 (4b) and 3.3 kcal/mol (5b), respectively, more stable than the respective complexes, having thiouracil ligands bound through the C2=X groups (X=O, 4a; S, 5a). For [PtMe3(bpy)(s2Ura-κS2)][BF4] (3) no preferred coordination mode could be assigned solely based on DFT calculations. Analysis of NMR spectra showed the κS2 coordination. In vitro cytotoxic studies of complexes 3-5 on nine different cell lines (8505C, A253, FaDu, A431, A549, A2780, DLD-1, HCT-8, HT-29) revealed in most cases moderate activities. However, 3 and 5 showed significant activity towards A549 and A2780, respectively, possessing IC50 values comparable to those of cisplatin. Cell cycle perturbations and trypan blue exclusion test on cancer cell line A431 using [PtMe3(bpy)(s 2s4Ura-κS4)][BF4] (5) showed induction of apoptotic cell death. Furthermore, the reaction of [PtMe 3(OAc-κ2O,O′)(Me2CO)] (6) with 4-thiouracil yielded the dinuclear complex [(PtMe3)2(μ-s 4Ura-H)2] (7), which has been characterized by microanalysis, NMR (1H, 13C, 195Pt) and IR spectroscopy as well as ESI mass spectrometry. X-ray diffraction analysis of crystals yielded in an isolated case exhibited the presence of a hexanuclear thiouracilato platinum(IV) complex, possessing each three different kinds of methyl platinum(IV) moieties and 4-thiouracilato ligands. This exhibited the ability of 4-thiouracil platinum(IV) complexes to form multinuclear complexes.
PB  - Elsevier
T2  - Inorganica Chimica Acta
T1  - Synthesis, characterization and in vitro cytotoxicity studies of platinum(IV) complexes with thiouracil ligands
VL  - 363
IS  - 11
SP  - 2452
EP  - 2460
DO  - 10.1016/j.ica.2010.03.079
ER  - 
@article{
author = "Vetter, Cornelia and Kaluđerović, Goran N. and Paschke, Reinhard and Kluge, Ralph and Schmidt, Jürgen and Steinborn, Dirk",
year = "2010",
abstract = "Reactions of [PtMe3(bpy)(Me2CO)][BF4] (2) with the thionucleobases 2-thiouracil (s2Ura), 4-thiouracil (s 4Ura) and 2,4-dithiouracil (s2s4Ura) resulted in the formation of complexes of the type [PtMe3 (bPy)(L-κS)] [BF4] (L= s2Ura, 3; s4Ura, 4; s 2s4Ura, 5). The complexes were characterized by NMR spectroscopy (1H, 13C, 195Pt), IR spectroscopy as well as microanalyses. The coordination through the C4=S groups (4, 5) was additionally confirmed by DFT calculations, where it was shown that these complexes [PtMe3(bpy)(L-κS4)]+ (L=s 4Ura, s2s4Ura) are about 5.8 (4b) and 3.3 kcal/mol (5b), respectively, more stable than the respective complexes, having thiouracil ligands bound through the C2=X groups (X=O, 4a; S, 5a). For [PtMe3(bpy)(s2Ura-κS2)][BF4] (3) no preferred coordination mode could be assigned solely based on DFT calculations. Analysis of NMR spectra showed the κS2 coordination. In vitro cytotoxic studies of complexes 3-5 on nine different cell lines (8505C, A253, FaDu, A431, A549, A2780, DLD-1, HCT-8, HT-29) revealed in most cases moderate activities. However, 3 and 5 showed significant activity towards A549 and A2780, respectively, possessing IC50 values comparable to those of cisplatin. Cell cycle perturbations and trypan blue exclusion test on cancer cell line A431 using [PtMe3(bpy)(s 2s4Ura-κS4)][BF4] (5) showed induction of apoptotic cell death. Furthermore, the reaction of [PtMe 3(OAc-κ2O,O′)(Me2CO)] (6) with 4-thiouracil yielded the dinuclear complex [(PtMe3)2(μ-s 4Ura-H)2] (7), which has been characterized by microanalysis, NMR (1H, 13C, 195Pt) and IR spectroscopy as well as ESI mass spectrometry. X-ray diffraction analysis of crystals yielded in an isolated case exhibited the presence of a hexanuclear thiouracilato platinum(IV) complex, possessing each three different kinds of methyl platinum(IV) moieties and 4-thiouracilato ligands. This exhibited the ability of 4-thiouracil platinum(IV) complexes to form multinuclear complexes.",
publisher = "Elsevier",
journal = "Inorganica Chimica Acta",
title = "Synthesis, characterization and in vitro cytotoxicity studies of platinum(IV) complexes with thiouracil ligands",
volume = "363",
number = "11",
pages = "2452-2460",
doi = "10.1016/j.ica.2010.03.079"
}
Vetter, C., Kaluđerović, G. N., Paschke, R., Kluge, R., Schmidt, J.,& Steinborn, D.. (2010). Synthesis, characterization and in vitro cytotoxicity studies of platinum(IV) complexes with thiouracil ligands. in Inorganica Chimica Acta
Elsevier., 363(11), 2452-2460.
https://doi.org/10.1016/j.ica.2010.03.079
Vetter C, Kaluđerović GN, Paschke R, Kluge R, Schmidt J, Steinborn D. Synthesis, characterization and in vitro cytotoxicity studies of platinum(IV) complexes with thiouracil ligands. in Inorganica Chimica Acta. 2010;363(11):2452-2460.
doi:10.1016/j.ica.2010.03.079 .
Vetter, Cornelia, Kaluđerović, Goran N., Paschke, Reinhard, Kluge, Ralph, Schmidt, Jürgen, Steinborn, Dirk, "Synthesis, characterization and in vitro cytotoxicity studies of platinum(IV) complexes with thiouracil ligands" in Inorganica Chimica Acta, 363, no. 11 (2010):2452-2460,
https://doi.org/10.1016/j.ica.2010.03.079 . .
11
12
13